Lymphofollicular Hyperplasia Overview
Learn About Lymphofollicular Hyperplasia
Lymphofollicular hyperplasia is an increase in the number of cells found in lymph node. These follicles contain normal white blood cells called lymphocytes. Your body produces more lymphocytes to help prevent bacteria, viruses, and other types of germs from entering the bloodstream. This may or may not be normal depending on why it occurs.
Lymphadenopathy; Lymphofollicular hypertrophy
Alberto Briganti practices in Milan, Italy. Mr. Briganti is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.
Francesco Montorsi practices in Milan, Italy. Mr. Montorsi is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.
Mamiko Yanagimoto-Sakata practices in Tsukuba, Japan. Ms. Yanagimoto-Sakata is rated as an Elite expert by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Bone Marrow Transplant, and Bone Graft.
Summary: This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab in treating patients with multiple myeloma, acute myeloid leukemia or lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory). VSV-IFNβ-NIS is a modified vers...
Summary: This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
Published Date: August 26, 2023
Published By: Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Winter JN. Approach to the patient with lymphadenopathy or splenomegaly. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 154.


